Level of chromosomal abnormality in lung cancer may predict immunotherapy response

Patients with non-small cell lung cancer (NSCLC) whose cancer cells have low levels of aneuploidy—an abnormal number of chromosomes—tend to respond better to immune checkpoint inhibitor drugs than patients with higher levels, Dana-Farber Cancer Institute researchers will report at the virtual AACR Annual Meeting 2021. In analyzing data from hundreds […]

PET/MRI, CT metrics assess pathologic response of pancreas cancer to neoadjuvant therapy

According to an open-access Editor’s Choice article in ARRS’ American Journal of Roentgenology (AJR), post-neoadjuvant therapy (NAT) changes in metabolic metrics from PET/MRI and morphologic metrics from CT were associated with pathologic response and overall survival in patients with pancreatic ductal adenocarcinoma (PDA). “Imaging metrics associated with pathologic response and […]